Paediatricians’ blood used to make new treatments for RSV and colds
New Scientist
February 18, 2026
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments
Verticals
science
Originally published on New Scientist on 2/18/2026